The Harvard Health Law Society had a lunch talk with former Attorney General and Governor of Wisconsin Jim Doyle. The former governor discussed his experiences tackling public health issues through state politics and joined us for a Q&A session about health policy, health law careers, and politics. Governor Jim Doyle served as the 44th governor…
The Petrie-Flom Center discussed how you can get involved at this gathering for faculty, colleagues, and students with shared interests in health law policy, biotechnology, and bioethics. We reviewed our sponsored research portfolio, introducde our staff and fellows, described various opportunities for students and others, and demonstrated key features on our website. The Open House…
Followed by Petrie-Flom’s 2014 Open House New healthcare start-ups face a range of legal and ethical challenges as they develop new products and services and solicit financial support from investors. Building on the success of the President’s Challenge at the Harvard Innovation Lab, which invites teams of Harvard students to develop innovative solutions to a…
A conversation with the Boston office of the U.S. Department of Health and Human Services Office of the Inspector General (OIG), Office of Evaluation and Inspections. The OIG has for decades served as the foremost government watchdog of federal healthcare programs, overseeing Medicare, Medicaid, the Food and Drug Administration, the National Institutes of Health, and…
Presentation Download the Presentation Topic Paper: “Solving the Problem of New Uses by Creating Incentives for Private Industry to Repurpose Off-Patent Drugs“ About the Presenter Benjamin N. Roin is Assistant Professor of Technological Innovation, Entrepreneurship, and Strategic Management at the MIT Sloan School of Management and an associate member of the Broad Institute of MIT…
Presentation Download the Presentation Topic Paper: Do “Reverse Payment” Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay? About the Presenter Thomas G. McGuire, PhD, is a professor of health economics in the Department of Health Care Policy at Harvard Medical School. His research focuses on the design and…
Who Clinical research sponsors, investigators, funders, regulators, trial participants, and other stakeholders Introduction & Background The term “post-trial access” is used broadly to connote a wide range of possibilities for providing continued access to study interventions (and potentially other care) once a trial is over, or a subject’s participation has ended. For the purposes of…
Presentation Download the Paper: “The Insurance Value of Medical Innovation” About the Presenter Anup Malani is the Lee and Brena Freeman Professor at the University of Chicago Law School and Professor at the Pritzker School of Medicine. He is also a university scholar at Resources for the Future in Washington, a research associate at the…
All Bill of Health bloggers and readers and friends of the Petrie-Flom Center who attended the annual ASLME Health Law Professors Conference were invited to a cocktail reception.
Symposium Presented by the Drug Information Association (DIA), the Food and Drug Law Institute (FDLI), and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, in collaboration with the Harvard School of Public Health Department of Biostatistics and Harvard Catalyst | The Harvard Clinical and Translational Science Center. Biostatistics is…
